1. Home
  2. Analysis
  3. Cefixime
  4. Mobic

Cefixime and Mobic drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cefixime and Mobic. Common interactions include abscess limb among females and chronic obstructive pulmonary disease among males.

The phase IV clinical study analyzes what interactions people who take Cefixime and Mobic have. It is created by eHealthMe based on reports of 10 people who take Cefixime and Mobic from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

10 people who take Cefixime and Mobic together, and have interactions are studied.

What is Cefixime?

Cefixime has active ingredients of cefixime. eHealthMe is studying from 2,169 Cefixime users for its effectiveness, alternative drugs and more.

What is Mobic?

Mobic has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 25,689 Mobic users for its effectiveness, alternative drugs and more.

Number of Cefixime and Mobic reports submitted per year:

Cefixime and Mobic drug interactions.

Common Cefixime and Mobic drug interactions by gender *:

female:

  1. Abscess limb
  2. Cerebrovascular accident
  3. Infection
  4. Joint injury
  5. Limb injury
  6. Localised infection
  7. Nephrolithiasis
  8. Osteomyelitis chronic
  9. Peripheral swelling
  10. Staphylococcal infection

male:

  1. Chronic obstructive pulmonary disease
  2. Infective glossitis
  3. Fatigue
  4. Feeling cold
  5. Neuropathy peripheral
  6. Oral surgery
  7. Sinusitis
  8. Sjogren's syndrome
  9. Sleep apnoea syndrome
  10. Spinal fusion surgery

Common Cefixime and Mobic drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Balance disorder
  2. Fall
  3. Feeling cold
  4. Neuropathy peripheral
  5. Sjogren's syndrome

50-59:

n/a

60+:

n/a

Common conditions people have *:

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 70.00%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 40.00%
  3. Infection: 1 person, 10.00%
  4. Immunodeficiency Common Variable: 1 person, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cefixime and Mobic?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Cefixime and Mobic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Cefixime side effects:

Browse all side effects of Cefixime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Mobic side effects:

Browse all side effects of Mobic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Cefixime interactions:

Browse all interactions between Cefixime and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Mobic interactions:

Browse all interactions between Mobic and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cefixime and meloxicam (the active ingredients of Cefixime and Mobic, respectively), and Cefixime and Mobic (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Cefixime and Mobic.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.